Cargando…
Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
BACKGROUND: A serious complication of heparin treatment, heparin-induced thrombocytopenia (HIT) is rarely observed in pregnant women. Drug therapy during pregnancy should always be chosen to minimize fetal risk. The management of HIT in pregnancy represents a medical challenge. Unlike heparins, the...
Autores principales: | Ciurzyński, Michał, Jankowski, Krzysztof, Pietrzak, Bronisława, Mazanowska, Natalia, Rzewuska, Ewa, Kowalik, Robert, Pruszczyk, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539579/ https://www.ncbi.nlm.nih.gov/pubmed/21525816 http://dx.doi.org/10.12659/MSM.881753 |
Ejemplares similares
-
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020) -
Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016) -
Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018) -
Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)